class name | count |
---|---|
rosids | 8 |
Magnoliophyta | 2 |
asterids | 1 |
eudicotyledons | 1 |
class name | count |
---|---|
Ganodermataceae | 49 |
Euphorbiaceae | 6 |
Coriolaceae | 6 |
Meliaceae | 2 |
Annonaceae | 2 |
Polyporaceae | 1 |
Gentianaceae | 1 |
Coulaceae | 1 |
Hypocreaceae | 1 |
Xylariaceae | 1 |
br08003 Category | # of metabolite |
---|
br08003 Category | KEGG ID | KNApSAcK ID |
---|
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00023777
![]() |
Lanosta-7,9(11),24-triene-3beta,21-diol
|
![]() |
||||
C00023782
![]() |
3beta-Hydroxylanosta-7,9(11),24-trien-21-oic acid
|
CHEMBL226995
CHEMBL2203608 |
![]() |
|||
C00023847
![]() |
Ganoderic acid S
/ (22S,24E)-22-Acetoxy-3alpha-hydroxy-5alpha-lanosta-7,9(11),24-trien-26-oic acid |
CHEMBL1097154
|
![]() |
|||
C00023853
![]() |
Ganoderic acid Y
/ 3beta-Hydroxy-5alpha-lanosta-7,9(11),24-trien-26-oic acid |
CHEMBL1915760
|
2 / 1 / 0 |
![]() |
||
C00023857
![]() |
Ganoderiol A
/ (+)-Ganoderiol A / 5alpha-Lanosta-7,9(11)-diene-3beta,24,25,26-tetraol |
![]() |
||||
C00023858
![]() |
Ganoderiol B
/ 15alpha,26,27-Trihydroxy-5alpha-lanosta-7,9(11),24-trien-3-one |
![]() |
||||
C00023859
![]() |
Ganoderiol C
|
![]() |
||||
C00023860
![]() |
Ganoderiol D
|
![]() |
||||
C00023861
![]() |
Ganoderiol E
|
![]() |
||||
C00023862
![]() |
Ganoderiol F
|
CHEMBL1915761
|
5 / 1 / 0 |
![]() |
||
C00023863
![]() |
Ganoderiol G
|
![]() |
||||
C00023864
![]() |
(+)-Ganoderiol H
|
![]() |
||||
C00023865
![]() |
Ganoderiol I
|
![]() |
||||
C00023866
![]() |
(+)-Ganodermanondiol
/ 24(S),25-Dihydroxy-5alpha-lanosta-7,9(11)-dien-3-one |
CHEMBL1098479
|
2 / 1 / 0 |
![]() |
||
C00023867
![]() |
Ganodermanontriol
/ 24(S),25,26-Trihydroxy-5alpha-lanosta-7,9(11)-dien-3-one |
CHEMBL1915763
CHEMBL1921821 CHEMBL1923792 CHEMBL1923793 |
3 / 1 / 0 |
![]() |
||
C00023868
![]() |
Ganodermadiol
/ 5alpha-Lanosta-7,9(11),24-triene-3beta,26-one |
CHEMBL240972
|
C050246
|
3 / 4 / 4 |
![]() |
|
C00023869
![]() |
Ganodermatriol
|
C050247
|
![]() |
|||
C00023873
![]() |
(+)-Ganolucidic acid D
/ 15alpha,23-Dihydroxy-3,11-dioxo-5alpha-lanosta-8,24E-dien-26-oic acid |
![]() |
||||
C00023874
![]() |
Ganolucidic acid E
/ 15alpha-Hydroxy-3,11-dioxo-5alpha-lanosta-8,24E-dien-26-oic acid |
CHEMBL2203593
|
![]() |
|||
C00030692
![]() |
Lucidumol A
/ (+)-Lucidumol A |
CHEMBL1917739
|
1 / 0 / 0 |
![]() |
||
C00030693
![]() |
Lucidumol B
|
CHEMBL1915762
|
2 / 1 / 0 |
![]() |
||
C00032435
![]() |
Tyromycic acid
|
CHEMBL1097154
|
![]() |
|||
C00033123
![]() |
Lucialdehyde A
|
CHEMBL515080
|
![]() |
|||
C00033124
![]() |
Lucialdehyde B
/ (+)-Lucialdehyde B |
CHEMBL463372
|
![]() |
|||
C00033125
![]() |
Lucialdehyde C
/ (+)-Lucialdehyde C |
![]() |
||||
C00033850
![]() |
Ganoderal A
/ (+)-Ganoderal A |
CHEMBL463972
|
![]() |
|||
C00033851
![]() |
Ganoderal B
/ (+)-Ganoderal B |
![]() |
||||
C00033852
![]() |
Ganoderic aldehyde A
/ (+)-Ganoderic aldehyde A |
CHEMBL490377
|
![]() |
|||
C00035009
![]() |
Carnosodione
/ 26,27-Dihydroxylanosta-7,9(11),24-triene-3,16-dione |
![]() |
||||
C00036339
![]() |
(20S)-Dammara-13(17),24-dien-3-one
/ (+)-(20S)-Dammara-13(17),24-dien-3-one |
![]() |
||||
C00036592
![]() |
5alpha-Lanosta-7,9(11),24-triene-3alpha,23-diol
/ (-)-5alpha-Lanosta-7,9(11),24-triene-3alpha,23-diol |
![]() |
||||
C00037647
![]() |
Pinicolol C
|
![]() |
||||
C00038066
![]() |
(+)-21-Hydroxylanosta-8,24-dien-3-one
|
![]() |
||||
C00038212
![]() |
21-Hydroxylanosta-7,9(11),24-trien-3-one
|
![]() |
||||
C00039068
![]() |
Dymacrin K
/ (-)-Dymacrin K |
![]() |
||||
C00042525
![]() |
Ganoderol A
|
CHEMBL463773
|
C050245
|
![]() |
||
C00042526
![]() |
Ganoderone A
|
CHEMBL457601
|
![]() |
|||
C00042527
![]() |
Ganoderone C
/ (-)-Ganoderone C |
CHEMBL516315
|
![]() |
|||
C00042706
![]() |
Lucialdehyde D
/ (+)-Lucialdehyde D |
![]() |
||||
C00042861
![]() |
Polycarpol
|
CHEMBL486808
CHEMBL1982726 |
2 / 0 / 0 |
![]() |
||
C00043676
![]() |
Lucidadiol
/ (+)-Lucidadiol |
CHEMBL1915764
|
2 / 1 / 0 |
![]() |
||
C00043992
![]() |
Tyromycic acid D
/ (-)-Tyromycic acid D |
CHEMBL479332
|
![]() |
|||
C00044417
![]() |
11-Oxo-kansenonol
/ (+)-11-Oxo-kansenonol |
CHEMBL469077
|
![]() |
|||
C00044744
![]() |
epi-Kansenone
/ (-)-epi-Kansenone |
CHEMBL469279
CHEMBL513851 |
![]() |
|||
C00044845
![]() |
Kansenol
|
![]() |
||||
C00044846
![]() |
Kansenone
|
CHEMBL469279
CHEMBL513851 |
![]() |
|||
C00044847
![]() |
Kansenonol
/ (+)-Kansenonol |
CHEMBL469076
CHEMBL1078419 |
1 / 0 / 0 |
![]() |
||
C00045224
![]() |
Antiquol C
/ (-)-Antiquol C |
CHEMBL517452
|
![]() |
|||
C00045319
![]() |
Ganoderic acid DM
|
CHEMBL1099224
|
1 / 3 / 4 |
![]() |
||
C00045821
![]() |
Daldinialanone
/ (+)-Daldinialanone |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P06276 | Cholinesterase | Hydrolase | C00023853 C00023862 C00023866 C00023867 C00023868 C00030693 C00043676 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00023853 C00023862 C00023866 C00023867 C00023868 C00030693 C00043676 | 1 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00023862 C00023867 C00030692 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00023868 C00045319 | 3 / 4 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00023862 | 0 / 0 |
Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00042861 | 0 / 0 |
P55055 | Oxysterols receptor LXR-beta | NR1H3 | C00042861 | 0 / 0 |
P11387 | DNA topoisomerase 1 | Isomerase | C00023862 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00044847 | 0 / 0 |
OMIM | preferred title | UniProt |
---|---|---|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|